1 year return (CAGR)
24.85%
BridgeBio Pharma Inc Exchange (NASDAQ, USD)
BBIO
66.58
-0.03 (-0.05%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
30.99%
5 year return (CAGR)
5.51%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
13.02B
Price/Sales
18.81
Ent value
16.06B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
2421.09
EPS growth
-0.56%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 67.01 |
| Daily high | 67.04 |
| Daily low | 65.78 |
| Daily Volume | 3.16M |
| All-time high | 90.17 |
| 1y analyst estimate | 109.10 |
| Beta | 0.98 |
| EPS (TTM) | -3.56 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Feb 2026 |
Downside potential
Loading...
Downside potential data
| BBIO | S&P500 | |
| Current price drop from All-time high | -26.16% | -0.56% |
| Highest price drop | -92.80% | -56.47% |
| Date of highest drop | 11 May 2022 | 9 Mar 2009 |
| Avg drop from high | -44.42% | -10.68% |
| Avg time to new high | 36 days | 12 days |
| Max time to new high | 1211 days | 1805 days |
News
